Guesnet P, Alessandri JM (2011). “Docosahexaenoic acid (DHA) and the developing central nervous system (CNS) - Implications for dietary recommendations”. 《Biochimie》 93 (1): 7–12. doi:10.1016/j.biochi.2010.05.005. PMID20478353.
Burdge, G. C.; Jones, A. E.; Wootton, S. A. (2002). “Eicosapentaenoic and docosapentaenoic acids are the principal products of α-linolenic acid metabolism in young men”. 《British Journal of Nutrition》 88 (4): 355–363. doi:10.1079/BJN2002662. PMID12323085.
Malone, J. Patrick (2012). “The Systems Theory of Autistogenesis: Putting the Pieces Together”. 《SAGE Open》 2 (2): 215824401244428. doi:10.1177/2158244012444281.
Giltay EJ, Gooren LJ, Toorians AW, Katan MB, Zock PL (2004). “Docosahexaenoic acid concentrations are higher in women than in men because of estrogenic effects”. 《The American Journal of Clinical Nutrition》 80 (5): 1167–74. doi:10.1093/ajcn/80.5.1167. PMID15531662.
Grey, Andrew; Bolland, Mark (March 2014). “Clinical Trial Evidence and Use of Fish Oil Supplements”. 《JAMA Internal Medicine》 174 (3): 460–462. doi:10.1001/jamainternmed.2013.12765. PMID24352849.
Serhan CN, Gotlinger K, Hong S, Arita M (2004). “Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis”. 《Prostaglandins Other Lipid Mediat.》 73 (3–4): 155–72. doi:10.1016/j.prostaglandins.2004.03.005. PMID15290791.
McNamara RK, Hahn CG, Jandacek R, 외. (2007). “Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder”. 《Biol. Psychiatry》 62 (1): 17–24. doi:10.1016/j.biopsych.2006.08.026. PMID17188654.
Westphal C, Konkel A, Schunck WH (Nov 2011). “CYP-eicosanoids--a new link between omega-3 fatty acids and cardiac disease?”. 《Prostaglandins & Other Lipid Mediators》 96 (1–4): 99–108. doi:10.1016/j.prostaglandins.2011.09.001. PMID21945326.
Sanders, T. A. (2009). “DHA status of vegetarians”. 《Prostaglandins, Leukotrienes and Essential Fatty Acids》 81 (2–3): 137–41. doi:10.1016/j.plefa.2009.05.013. PMID19500961.
Lane, K; Derbyshire, E; Li, W; Brennan, C (2014). “Bioavailability and potential uses of vegetarian sources of omega-3 fatty acids: A review of the literature”. 《Critical Reviews in Food Science and Nutrition》 54 (5): 572–9. doi:10.1080/10408398.2011.596292. PMID24261532.
Zargar, Atanaz; Ito, Matthew K. (2011년 8월 1일). “Long chain omega-3 dietary supplements: a review of the National Library of Medicine Herbal Supplement Database”. 《Metabolic Syndrome and Related Disorders》 9 (4): 255–271. doi:10.1089/met.2011.0004. ISSN1557-8518. PMID21787228.
Carlson BA, Kingston JD (2007). “Docosahexaenoic acid biosynthesis and dietary contingency: Encephalization without aquatic constraint”. 《Am. J. Hum. Biol.》 19 (4): 585–8. doi:10.1002/ajhb.20683. PMID17546613.
Crawford, M; 외. (2000). “Evidence for the unique function of docosahexaenoic acid (DHA) during the evolution of the modern hominid brain”. 《Lipids》 34 (S1): S39–S47. doi:10.1007/BF02562227. PMID10419087.
Guesnet P, Alessandri JM (2011). “Docosahexaenoic acid (DHA) and the developing central nervous system (CNS) - Implications for dietary recommendations”. 《Biochimie》 93 (1): 7–12. doi:10.1016/j.biochi.2010.05.005. PMID20478353.
Burdge, G. C.; Jones, A. E.; Wootton, S. A. (2002). “Eicosapentaenoic and docosapentaenoic acids are the principal products of α-linolenic acid metabolism in young men”. 《British Journal of Nutrition》 88 (4): 355–363. doi:10.1079/BJN2002662. PMID12323085.
Giltay EJ, Gooren LJ, Toorians AW, Katan MB, Zock PL (2004). “Docosahexaenoic acid concentrations are higher in women than in men because of estrogenic effects”. 《The American Journal of Clinical Nutrition》 80 (5): 1167–74. doi:10.1093/ajcn/80.5.1167. PMID15531662.
Grey, Andrew; Bolland, Mark (March 2014). “Clinical Trial Evidence and Use of Fish Oil Supplements”. 《JAMA Internal Medicine》 174 (3): 460–462. doi:10.1001/jamainternmed.2013.12765. PMID24352849.
Serhan CN, Gotlinger K, Hong S, Arita M (2004). “Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis”. 《Prostaglandins Other Lipid Mediat.》 73 (3–4): 155–72. doi:10.1016/j.prostaglandins.2004.03.005. PMID15290791.
McNamara RK, Hahn CG, Jandacek R, 외. (2007). “Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder”. 《Biol. Psychiatry》 62 (1): 17–24. doi:10.1016/j.biopsych.2006.08.026. PMID17188654.
Westphal C, Konkel A, Schunck WH (Nov 2011). “CYP-eicosanoids--a new link between omega-3 fatty acids and cardiac disease?”. 《Prostaglandins & Other Lipid Mediators》 96 (1–4): 99–108. doi:10.1016/j.prostaglandins.2011.09.001. PMID21945326.
Sanders, T. A. (2009). “DHA status of vegetarians”. 《Prostaglandins, Leukotrienes and Essential Fatty Acids》 81 (2–3): 137–41. doi:10.1016/j.plefa.2009.05.013. PMID19500961.
Lane, K; Derbyshire, E; Li, W; Brennan, C (2014). “Bioavailability and potential uses of vegetarian sources of omega-3 fatty acids: A review of the literature”. 《Critical Reviews in Food Science and Nutrition》 54 (5): 572–9. doi:10.1080/10408398.2011.596292. PMID24261532.
Zargar, Atanaz; Ito, Matthew K. (2011년 8월 1일). “Long chain omega-3 dietary supplements: a review of the National Library of Medicine Herbal Supplement Database”. 《Metabolic Syndrome and Related Disorders》 9 (4): 255–271. doi:10.1089/met.2011.0004. ISSN1557-8518. PMID21787228.
Carlson BA, Kingston JD (2007). “Docosahexaenoic acid biosynthesis and dietary contingency: Encephalization without aquatic constraint”. 《Am. J. Hum. Biol.》 19 (4): 585–8. doi:10.1002/ajhb.20683. PMID17546613.
Crawford, M; 외. (2000). “Evidence for the unique function of docosahexaenoic acid (DHA) during the evolution of the modern hominid brain”. 《Lipids》 34 (S1): S39–S47. doi:10.1007/BF02562227. PMID10419087.
Zargar, Atanaz; Ito, Matthew K. (2011년 8월 1일). “Long chain omega-3 dietary supplements: a review of the National Library of Medicine Herbal Supplement Database”. 《Metabolic Syndrome and Related Disorders》 9 (4): 255–271. doi:10.1089/met.2011.0004. ISSN1557-8518. PMID21787228.